ATE471519T1 - Diagnose neurodegenerativer krankheiten - Google Patents

Diagnose neurodegenerativer krankheiten

Info

Publication number
ATE471519T1
ATE471519T1 AT05823285T AT05823285T ATE471519T1 AT E471519 T1 ATE471519 T1 AT E471519T1 AT 05823285 T AT05823285 T AT 05823285T AT 05823285 T AT05823285 T AT 05823285T AT E471519 T1 ATE471519 T1 AT E471519T1
Authority
AT
Austria
Prior art keywords
swissprot acc
acc
protein
swissprot
precursor
Prior art date
Application number
AT05823285T
Other languages
English (en)
Inventor
Malcolm Andrew Ward
John Collinge
Graham Stuart Jackson
Emma Mcgregor
Nicola Louise Leeds
James Campbell
Jules Westbrook
Helen Byers
Original Assignee
Electrophoretics Ltd
Medical Res Council
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Electrophoretics Ltd, Medical Res Council, Univ London filed Critical Electrophoretics Ltd
Priority claimed from PCT/GB2005/004698 external-priority patent/WO2006061609A2/en
Application granted granted Critical
Publication of ATE471519T1 publication Critical patent/ATE471519T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05823285T 2004-12-07 2005-12-07 Diagnose neurodegenerativer krankheiten ATE471519T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0426859.5A GB0426859D0 (en) 2004-12-07 2004-12-07 Diagnosis of neurodegenerative disorders
GBGB0521762.5A GB0521762D0 (en) 2004-12-07 2005-10-25 Diagnosis of neurodegenerative disorders
PCT/GB2005/004698 WO2006061609A2 (en) 2004-12-07 2005-12-07 Diagnosis of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
ATE471519T1 true ATE471519T1 (de) 2010-07-15

Family

ID=34073345

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05820667T ATE449345T1 (de) 2004-12-07 2005-12-07 Monitorierung von huntington's disease
AT05823285T ATE471519T1 (de) 2004-12-07 2005-12-07 Diagnose neurodegenerativer krankheiten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05820667T ATE449345T1 (de) 2004-12-07 2005-12-07 Monitorierung von huntington's disease

Country Status (5)

Country Link
US (2) US9028801B2 (de)
AT (2) ATE449345T1 (de)
DE (2) DE602005017819D1 (de)
ES (2) ES2344118T3 (de)
GB (2) GB0426859D0 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100105776A (ko) 2008-01-18 2010-09-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
CA2806310A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
CA2806293A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
CA2806291C (en) 2010-07-23 2023-08-29 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
ES2656150T3 (es) 2011-11-14 2018-02-23 Universitätsklinikum Jena Diagnóstico de la sepsis y del síndrome de respuesta inflamatoria sistémica
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
WO2014164366A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting cancer
EP2965086A4 (de) 2013-03-09 2017-02-08 Harry Stylli Verfahren zum nachweis von prostatakrebs
EP3693742B1 (de) 2014-09-11 2022-04-06 Harry Stylli Verfahren zum nachweis von prostatakrebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824988B2 (en) 2000-05-15 2004-11-30 R.E.D. Laboratories, N.V. Method and compositions for use in diagnosing and characterizing chronic immune disease
GB0026604D0 (en) * 2000-10-31 2000-12-13 Roslin Inst Edinburgh Diagnostic method
US20060094039A1 (en) * 2004-09-20 2006-05-04 Ron Rosenfeld Diagnosis of fetal aneuploidy
GB0421639D0 (en) * 2004-09-29 2004-10-27 Proteome Sciences Plc Methods and compositions relating to alzheimer's disease
US7704708B2 (en) * 2006-02-13 2010-04-27 Uti Limited Partnership Monomeric streptavidin muteins

Also Published As

Publication number Publication date
US8506957B2 (en) 2013-08-13
ES2333892T3 (es) 2010-03-02
ATE449345T1 (de) 2009-12-15
US9028801B2 (en) 2015-05-12
US20080213802A1 (en) 2008-09-04
ES2344118T3 (es) 2010-08-18
US20080286263A1 (en) 2008-11-20
GB0426859D0 (en) 2005-01-12
DE602005021912D1 (de) 2010-07-29
DE602005017819D1 (de) 2009-12-31
GB0521762D0 (en) 2005-11-30

Similar Documents

Publication Publication Date Title
ATE471519T1 (de) Diagnose neurodegenerativer krankheiten
WO2006061609A3 (en) Diagnosis of neurodegenerative diseases
Osbourn et al. HpARI protein secreted by a helminth parasite suppresses interleukin-33
WO2006086799A3 (en) Prion-specific peptide reagents
FR21C1004I2 (fr) Utilisation de la proteinase ides (de s. pyogenes) pour le traitement des maladies autoimmunes et du rejet de greffe
CY2016039I1 (el) Χιμαιρικες πρωτεϊνες παραγοντα πηξης για την αγωγη αιμοστατικων ασθενειων
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
WO2008008482A3 (en) Altered br3-binding polypeptides
NI200600098A (es) Anticuerpos que se unen al receptor de interleuquina-4
WO2007068985A3 (en) Diagnosis and prognosis of colorectal cancer
WO2008122670A3 (en) Human diabetes susceptibility tnfrsf10b gene
WO2008037449A3 (en) Use of at least one isoform of progesterone receptor membrane component 1 (pgrmc1)
PT1214600E (pt) Determinacao de proteinas de ligacao a adrenomedulina
WO2005056585A3 (en) Sars coronavirus s proteins and uses thereof
WO2006137938A3 (en) Antibody fragments for protection from pathogen infection and methods of use thereof
DE602007009116D1 (de) Zusammensetzungen und verfahren zur verabreichung anti-aktivierter ras-antikörper an zellen
AU2002341090A1 (en) Use of a protein of the crmp family for treating diseases related to the immune system
Parambeth et al. Purification and partial characterization of α1-proteinase inhibitor in the common marmoset (Callithrix jacchus)
WO2004007555A3 (en) Detection of prion disease
WO2004113386A3 (en) Modified hirudin proteins and t-cell epitopes in hirudin
Johansen et al. Complement factor C5 in Atlantic salmon (Salmo salar): Characterization of cDNA, protein and glycosylation
WO2005005471A3 (en) Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
EP1903109B8 (de) Menschliche Protein Phosphatase mit EF-Hände-1 (PPEF-1)- betreffende Genvariante assoziert mit dem T-Zellen lymphoblastischen Lymphom

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties